Bullish
Moncef Slaoui joins Vaxcyte (NASDAQ: PCVX) board as director
Vaxcyte, Inc. announced that Moncef Slaoui has been appointed as a Class II independent director to its board, effective June 17, 2026, with his term ...
Vaxcyte, Inc. announced that Moncef Slaoui has been appointed as a Class II independent director to its board, effective June 17, 2026, with his term ...